N,N-Diethylphenethylamine|CAS 1126-71-2|DC Chemicals

Cas No.:	1126-71-2
Chemical Name:	N,N-Dimethyl-2-phenylethanamine
Synonyms:	Benzeneethanamine,N,N-dimethyl-;N,N-DIMETHYL-2-PHENYLETHANAMINE;N,N-DIMETHYL-N-PHENETHYLAMINE;(2-phenylethyl)dimethylamine;2-phenylethyl-N,N-dimethylamine;4-dimethylaminoethyl benzene;Benzeneethanamine,dimethyl;Benzeneethanamine,N,N-dimethyl;dimethylphenethylamine;N,N-dimethyl-(2-phenylethyl)amine;N,N-dimethyl-1-phenyl-2-ethanamine;N,N-Dimethylbenzeneethanamine;N,N-Dimethylphenethylamine;N,N-Dimethylphenylethylamine;N-Phenethyldimethylamine;Phenethylamine,N,N-dimethyl;N-(2-Phenylethyl)dimethylamine;NSC 1849;[(Dimethylamino)ethyl]benzene;N,N-Dimethyl-beta-phenethylamine;2-phenylethyl-n,n-dimethylamine;Dimethyl-phenethyl-amine;CHEBI:188983;FT-0633374;A802628;BDBM50018453;AMY25101;Q27280434;SCHEMBL168948;N,N-DIMETHYL-1-PHENYL-2-ETHANAMINE;NSC1849;UNII-I4C10U12C8;Z168912026;dimethyl(2-phenylethyl)amine;NSC-1849;InChI=1/C10H15N/c1-11(2)9-8-10-6-4-3-5-7-10/h3-7H,8-9H2,1-2H;AF 2975;CHEMBL46278;AKOS015917648;N,N-dimethyl-2-phenyl-ethanamine;N,N-Dimethyl-2-phenylethylamine;N,N-Dimethylphenethylamine, 98%;N-PHENETHYL DIMETHYLAMINE;EN300-322015;Benzeneethanamine, dimethyl-;F12472;N,N-Dmpea;N,N-Dimethyl-.beta.-phenethylamine;J-002814;n,n-dimethyl-beta-phenylethylamine;A936484;Benzeneethanamine, N,N-dimethyl-;Phenethylamine, N,N-dimethyl-;DTXSID40150114;Dimethylaminoethylbenzene;2-dimethylamino-1-phenylethane;N,N-Dimethyl-2-phenylethanamine;N,N-Dimethyl-2-phenethylamine;N,N-Dimethyl-N-phenethylamine;Dimethylphenethylamine;Phenethylamine,N-dimethyl-;PD126403;1126-71-2;I4C10U12C8;MFCD00177940;DB-041110
SMILES:	CN(C)CCC1=CC=CC=C1
Formula:	C₁₀H₁₅N
M.Wt:	149.2328
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Cat. No.	Product name	Field of application
DC31074	Isopropyl myristate	Isopropyl myristate is the ester of isopropyl alcohol and myristic acid.
DC75868	AZ14133346	AZ14133346 (compound 36) is a potent and selective inhibitor of EGFR Exon20 insertions, with the IC50 of 85 nM. AZ14133346 plays an important role in cancer research.
DC75865	TI17	TI17 represents a novel class of targeted anticancer agents that specifically disrupt DNA damage repair mechanisms in malignant cells.
DC75816	Nisoxetine	Nisoxetine acts as a highly selective and potent noradrenaline transporter (NET) antagonist, exhibiting a binding affinity (Kd) of 0.76 nM. In addition to its antidepressant properties, nisoxetine functions as a local anesthetic by inhibiting voltage-gated sodium channels. This dual pharmacological activity makes it a compound of interest for both neurological and pain management research.
DC75641	GENZ-644282 TFA salt	Genz-644282, also known as SAR402674, is a non-camptothecin inhibitor of topoisomerase I with potential antineoplastic activity. Topoisomerase I inhibitor Genz-644282 binds to and inhibits the enzyme topoisomerase I, which may result in the inhibition of repair of single-strand DNA breaks, DNA replication, and tumor cell growth in susceptible tumor cell populations.
DC75325	PSMA-617 TFA	PSMA-617, also know as vipivotide tetraxetan, is a ligand used to make 177Lu-PSMA-617, which is a radioactive molecule to fight cancer. PSMA617 possesses a small peptide, which was designed to target prostate-specific membrane antigen (PSMA). PSMA617 demonstrates high radiolytic stability for at least 72 h. PSMA617 has high inhibition potency (equilibrium dissociation constant Ki=2.34±2.94 nM on LNCaP; Ki=0.37±0.21 nM enzymatically determined). 177 Lu-PSMA-617 offers a potential additional life-prolonging treatment option for men with mCRPC.
DC75202	Fosaprepitant free acid	Fosaprepitant, also known as MK0517, is an antiemetic drug, administered intravenously. It is a prodrug of aprepitant. Fosaprepitant was developed by Merck & Co. and was approved. It is a prodrug of Aprepitant. It aids in the prevention of acute and delayed nausea and vomiting associated with chemotherapy treatment. Fosaprepitant is a weak inhibitor of CYP3A4, and aprepitant, the active moiety, is a substrate, inhibitor, and inducer of CYP3A4
DC74748	O4I4	O4I4 (compound 23) is a OCT4-inducing compound with metabolical stability.
DC74684	ZH8667	ZH8667 is a trace amine-associated receptor 1 (TAAR1)–Gs agonist.
DC74646	EB-PSMA-617	EB-PSMA-617 is an Evans blue-modified prostate-specific membrane antigen (PSMA) 617 ligand for making 177Lu-EB-PSMA, which is potential useful for Metastatic Castration-Resistant Prostate Cancer.